See this article In Transfusion Magazine: Issue Dodd, R. (2010), Direct assessment of cytomegalovirus transfusion-transmitted risks after universal leukoreduction. Transfusion, 50: 776–786. Basically after studying baseline sero-negative patients, the risk of CMV-TTD is around 6.5% after universal leukoreduction.